Oncocross Co., Ltd. (KOSDAQ:382150)

Oncocross Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	284.86	2,797	15,342	11,642	3,192	1,651
Short-Term Investments	21,804	17,125	-	5,000	3,000	3,000
Trading Asset Securities	3,078	3,511	5,409	-	815.93	9,589
Cash & Short-Term Investments	25,167	23,433	20,751	16,642	7,008	14,241
Cash Growth	54.06%	12.92%	24.69%	137.47%	-50.79%	-19.91%
Accounts Receivable	33	44.87	220	-	-	-
Other Receivables	397.85	194.06	12.63	22.69	4.31	1.61
Receivables	430.85	238.93	232.63	22.69	4.31	1.61
Prepaid Expenses	981.76	464.52	41.82	53.98	124.15	82.77
Other Current Assets	189.22	75.65	74.93	44.76	59.79	26.68
Total Current Assets	26,769	24,212	21,101	16,763	7,196	14,352
Property, Plant & Equipment	3,222	3,578	1,012	565.96	976.29	560.66
Long-Term Investments	2,000	-0	0	0	0	0
Other Intangible Assets	56.07	48.29	37.85	47.24	50.62	57.61
Other Long-Term Assets	276.81	1,120	397.15	209.18	177.07	132.13
Total Assets	32,324	28,957	22,548	17,586	8,400	15,102

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accrued Expenses	105.88	670.4	573.36	558.44	224.35	191.78
Current Portion of Leases	217.14	277.14	306.33	115.89	202.41	69.87
Current Income Taxes Payable	-	-	-	109.86	-	-
Other Current Liabilities	9,714	4,807	968.75	314.81	1,143	1,547
Total Current Liabilities	18,647	5,754	1,848	1,099	1,570	1,809
Long-Term Debt	-	5,040	-	-	-	2,118
Long-Term Leases	111.25	42.96	242.61	-	115.89	-
Other Long-Term Liabilities	3	4,748	-	-	0	-
Total Liabilities	18,761	15,585	2,091	1,099	1,686	3,927

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	6,098	6,014	5,929	5,196	4,401	712.59
Additional Paid-In Capital	63,857	62,951	61,911	52,513	37,640	37,905
Retained Earnings	-59,747	-58,124	-49,195	-42,712	-38,498	-28,294
Comprehensive Income & Other	3,355	2,531	1,812	1,489	1,152	850.15
Total Common Equity	13,562	13,372	20,457	16,487	4,695	11,175
Shareholders' Equity	13,562	13,372	20,457	16,487	6,715	11,175
Total Liabilities & Equity	32,324	28,957	22,548	17,586	8,400	15,102

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	8,938	5,360	548.94	115.89	318.3	2,188
Net Cash (Debt)	16,229	18,073	20,202	16,526	6,690	12,052
Net Cash Growth	1.67%	-10.54%	22.24%	147.03%	-44.49%	387.40%
Net Cash Per Share	1342.50	1511.46	1928.88	1854.72	761.64	2246.77
Filing Date Shares Outstanding	12.2	12.03	11.86	10.39	8.8	8.55
Total Common Shares Outstanding	12.2	12.03	11.86	10.39	8.8	8.55
Working Capital	8,122	18,457	19,252	15,664	5,627	12,543
Book Value Per Share	1112.04	1111.73	1725.17	1586.45	533.45	1306.81
Tangible Book Value	13,506	13,324	20,419	16,440	4,644	11,117
Tangible Book Value Per Share	1107.44	1107.72	1721.98	1581.91	527.70	1300.07
Machinery	2,583	2,885	169.2	411.85	737.45	628.31
Construction In Progress	-	-	61.02	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 17, 2026

Data Sources Report a data error